Skip to main content

University of Missouri

News

Research

Overactive Cells Linked to Type 2 Diabetes

Researchers from the University of Missouri are studying potential therapies to target specific cells linked to the development of cardiovascular and metabolic disorders like high blood pressure and type 2 diabetes.

MU Researchers Join Cancer Prevention Network

MU is one of four institutions nationwide to receive National Cancer Institute funding for research on activating the immune system against cancer.

Student Success Story: Brett Boney

Boney conducts research in the lab of Bret Ulery, an associate professor in the College of Engineering and researcher with NextGen Precision Health. The lab focuses, in part, on analyzing novel polymer-based products to ultimately improve regenerative medicine.

Brad's Bites: Kathryn Moss Interview

Dr. Kathryn Moss is studying a disease she's also been diagnosed with, CMT, at Mizzou. She joined us to discuss her research on the latest Brad's Bites.

New Study Shows Diet, Exercise Reverses Liver Damage

New research from the University of Missouri School of Medicine suggests intensive lifestyle interventions are an effective way of treating and improving liver disease.

Corinna Singleman Chats with Smita Saxena

Smita Saxena, PhD, is a lifelong learner who has dedicated her life to unraveling the circuitry of the brain and the diseases tied up in it, like amyotrophic lateral sclerosis (ALS) and Alzheimer’s disease (AD).

Changing Cystic Fibrosis Care, One Less Cough at a Time: Hannah’s Story

Coughing was just a fact of life for Hannah Gryder. For as long as her grandmother, Tina Wood, can remember, the rasping noise and chest spasms would disrupt Hannah’s sleep.

Five Ways Mizzou is Helping Lead America’s Fight Against Cancer

Two researchers are joining a national cancer-fighting network in the latest example of Mizzou’s dedication to finding a cure.

Sleep Apnea May Increase Risk of Abdominal Aortic Aneurysms

Obstructive sleep apnea may be a risk factor for developing abdominal aortic aneurysms, according to researchers from the University of Missouri School of Medicine and NextGen Precision Health.

Paving the Way for New Treatments

Mizzou researcher Jianlin “Jack” Cheng debuts tool to build 3D structure of protein complexes, giving scientists insights to prevent and treat disease.

Immunologist Earns Global Transplantation Honor

Haval Shirwan, PhD, an inventor on 29 issued and nine pending patents and a co-founder of three biotech startups, is receiving a distinction from his global peers that is only bestowed every two years. The world’s premier association for transplantation science will honor Shirwan’s career working toward safe and effective immunomodulation.

Clearing the Way for Healthy Arteries

A trio of researchers in Mizzou’s Roy Blunt NextGen Precision Health building have developed a treatment for a leading cause of heart disease in America.

Tom Spencer Leads By Example

Mizzou’s Vice Chancellor for Research has spent decades researching the reproductive system. Now, he’s continuing to lead research into women’s reproductive health with support from a NIH MERIT Award.

Targeted Cancer Cell Therapy May Slow Endometrial Cancer

There may be a way to slow the growth of endometrial cancer through targeted cancer cell therapy, according to new research from the University of Missouri School of Medicine.

Mizzou researcher Dong Xu weighs in on future of artificial intelligence

Artificial intelligence (AI) can write, create videos and power self-driving cars. Someday, University of Missouri researcher Dong Xu predicts, it also will perform surgeries.

Students earn hands-on experience through Summer Research Fellowship Program

Each year, the MU School of Medicine Summer Research Fellowship Program supports original student research under the direct supervision of a faculty member. Students who have completed their first year of medical school are eligible to apply for the program. This summer, 75 medical students participated in the program.

Diabetes Drug Reduces Drug Resistance in Lung Cancer

A medication used to treat diabetic neuropathy may make chemotherapy treatments more effective for patients with lung cancer, according to new findings from NextGen Precision Health researchers.

Cracking the Code on Rare Disease Research

Joining the University of Missouri’s NextGen Precision Health team was a logical next step for Kathryn Moss, a neuroscientist intent on understanding Charcot-Marie-Tooth disease.

Harnessing Cancer's Nemesis

Diana Gil Pagés and her team are weaponizing the immune system against cancer. Learn more about their individualized health care approach.

University of Missouri Researcher Awarded $2.2 Million for Non-Radiation Imaging Research

The team is developing a new method for imaging inflammation disorders, such as inflammatory bowel disease (IBD), autoimmune diseases and arthritis.